Literature DB >> 26924471

History and future of genetically engineered food animal regulation: an open request.

Kevin D Wells1.   

Abstract

Modern biotechnology resulted from of a series of incremental improvements in the understanding of DNA and the enzymes that nature evolved to manipulate it. As the potential impact of genetic engineering became apparent, scientists began the process of trying to identify the potential unintended consequences. Restrictions to recombinant DNA experimentation were at first self-imposed. Collaborative efforts between scientists and lawyers formalized an initial set of guidelines. These guidelines have been used to promulgate regulations around world. However, the initial guidelines were only intended as a starting point and were motivated by a specific set of concerns. As new data became available, the guidelines and regulations should have been adapted to the new knowledge. Instead, other social drivers drove the development of regulations. For most species and most applications, the framework that was established has slowly allowed some products to reach the market. However, genetically engineered livestock that are intended for food have been left in a regulatory state of limbo. To date, no genetically engineered food animal is available in the marketplace. A short history and a U.S.-based genetic engineer's perspective are presented. In addition, a request to regulatory agencies is presented for consideration as regulation continues to evolve. Regulators appear to have shown preference for the slow, random progression of evolution over the efficiency of intentional design.

Keywords:  Genetic engineering; Genetically engineered food; Regulations

Mesh:

Year:  2016        PMID: 26924471     DOI: 10.1007/s11248-016-9935-7

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  29 in total

1.  Federal agency on gene splicing proposed.

Authors:  Philip J Hilts
Journal:  Washington Post       Date:  1982-11-17

2.  Personal reflections on the origins and emergence of recombinant DNA technology.

Authors:  Paul Berg; Janet E Mertz
Journal:  Genetics       Date:  2010-01       Impact factor: 4.562

3.  Letter: Potential biohazards of recombinant DNA molecules.

Authors:  P Berg; D Baltimore; H W Boyer; S N Cohen; R W Davis; D S Hogness; D Nathans; R Roblin; J D Watson; S Weissman; N D Zinder
Journal:  Science       Date:  1974-07-26       Impact factor: 47.728

4.  Construction of biologically functional bacterial plasmids in vitro.

Authors:  S N Cohen; A C Chang; H W Boyer; R B Helling
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

5.  Summary statement of the Asilomar conference on recombinant DNA molecules.

Authors:  P Berg; D Baltimore; S Brenner; R O Roblin; M F Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

6.  Advancing swine models for human health and diseases.

Authors:  Eric M Walters; Randall S Prather
Journal:  Mo Med       Date:  2013 May-Jun

7.  Production of transgenic rabbits, sheep and pigs by microinjection.

Authors:  R E Hammer; V G Pursel; C E Rexroad; R J Wall; D J Bolt; K M Ebert; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

8.  Genetic fusion of incompatible plasmids in Pseudomonas.

Authors:  A M Chakrabarty
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

9.  Teratocarcinoma cells as vehicles for mutant and foreign genes.

Authors:  B Mintz
Journal:  Brookhaven Symp Biol       Date:  1977 May 12-20

10.  Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal.

Authors:  R Jaenisch; H Fan; B Croker
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.